Navigation Links
Pilot Testing Phase Ends; Expansion Of Sales Force Begins
Date:4/13/2010

PreEmptive Meds, Inc., a plant-based pharma-nutraceutical company, which promotes its proprietary, all-natural formulations as evidence-based alternatives for the primary care physician, announces the completion of its pilot testing phase and its initiation of sales force expansion.

Whitehouse Station, NJ/Las Vegas, NV (PRWEB) April 14, 2010 -- PreEmptive Meds, Inc., a plant-based pharma-nutraceutical company, which promotes its proprietary, all-natural formulations as evidence-based alternatives for the primary care physician, announces the completion of its pilot testing phase and its initiation of sales force expansion.

Over the past three years, the company has been promoting, on a pilot test basis, its current product line with experienced pharmaceutical-trained sales associates to physicians in selected pockets of northern New Jersey, New York City and Long Island, NY with favorable acceptance and patient outcomes. The Company has now expanded its sales effort to 16 sales associates and plans to continue its expansion to 30 sales associates by July 1st, 2010. The current sales effort is and will be focused up and down the east coast corridor from Massachusetts to Florida, and into Texas, Pennsylvania and Illinois. Expansion is planned to continue throughout 2011 with the goal to have a national sales effort within prominent high-density metropolitan Primary Care Physician areas across the country.

The Company currently promotes seven products: PreCrea® for pre-diabetes; PreLipid® and PreLipid Plus®, for lowering cholesterol naturally; PreMenora® and PreMenora®Plus, for relieving symptoms of perimenopause; and PreArthros™, and PreArthros™Plus for joint inflammation and pain, via a pharmaceutical style sales force. In addition, the Company has also developed a series of new formulations as viable all-natural alternatives for various chronic conditions, which it plans to launch over time once it has established a sufficient beachhead with its current product line with Primary Care Physicians.

Chuck Blitzer, the Company’s Chief Executive Officer stated, “We are extremely pleased with the results from our pilot testing program (which reached over 1,500 physicians and over 200,000 patient experiences) and now, our effort to formally begin building a national sales organization. Our sales associates are highly proven individuals from the pharmaceutical industry and average over 12 years of direct selling experience within the Primary Care Physician community, the largest physician audience in the country.

Our products are recommended by thousands of physicians as:

1) First-line therapy for pre-disease states, where no prescription drugs are approved,
2) An alternative for patients who are intolerant to prescription drugs or refuse to go onto a prescription drug, and
3) Additive therapy to a given prescription drug where the desired therapeutic effect of such drug has not been achieved and the physician is inclined not to increase dose.”

The Company’s financial position is sound and it hasn’t needed to raise capital since its last round of financing in 2008. It is debt free and believes it is on track to break-even by years’ end.

Dr. Joe Fenn, President and Chief Medical Officer stated “From our pilot program we learned how to promote our products effectively to Primary Care Physicians, and in every sales territory we now expand to we have doctors eager to hear our message and adopt our products as alternatives for their patients. We have also established the efficacy and safety of our products in tens of thousands of patients. ”

PreEmptive Meds, Inc., is a pre-disease focused, plant-based pharma-nutraceutical company promoting its proprietary branded products directly to the Primary Care Physician community.

###

Read the full story at http://www.prweb.com/releases/preemptivemeds/salesteam/prweb3865604.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. HealthEquity Partners with State of Utah to Launch Pilot of Utah Health Exchange
2. Howard Leights New Pilot Push-in Ear Plug Delivers Occupational Hearing Protection with Innovative, Hybrid Design
3. Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges
4. Edifecs Testifies Before NCVHS Standards Subcommittee Regarding HIPAA 5010 and ICD-10 Testing
5. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
6. The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao
7. AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions
8. ANY LAB TEST NOW North Dallas Lowers Diabetes Testing to $89
9. Refinement of glaucoma testing, treatment expected from US, United Kingdom study
10. Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification
11. Statement from American Water Works Association on the Environmental Working Group's report on Tap Water Quality Testing and Violations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pilot Testing Phase Ends; Expansion Of Sales Force Begins
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/21/2017)... , ... April 21, 2017 , ... An April 10 ... a pair of ancient teeth, which reveal a great deal about prehistoric ice-age dental ... sharp stone may have been used to remove decayed dental matter, and that teeth ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. ... osteoma is a benign bony lump located on the forehead usually attributed to a ... with sight and pain. Dr. Shah has discovered an approach that is minimally invasive. ...
(Date:4/21/2017)... ... 21, 2017 , ... Dudnyk has announced the launch of its new brand ... full potential of specialty and orphan brands can only be achieved when the needs ... Unifying Effect is at the heart of a true partnership between our agency and ...
(Date:4/21/2017)... ... , ... The Hong Kong Polytechnic University (PolyU) launched today the University Research ... in Hong Kong to support teaching, learning and research. It is also the largest ... in Hong Kong. , With an area of 620 square metres and more ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... -- Research and Markets has announced the addition ... Equipment and Radiopharmaceuticals Market, Forecast to 2023" report to ... This ... well as growth in the number of unit shipments over ... participants that design and manufacture molecular imaging equipment. ...
(Date:4/18/2017)... LAKE CITY , April 18, 2017 ... combines innovative biological science with machine learning techniques to ... has hired Dr. Yolanda Chong as vice ... years at Johnson & Johnson in Belgium ... a team that focused on applying high-dimensional biological approaches ...
(Date:4/18/2017)... 2017 Research and Markets has announced the ... to their offering. ... antiviral drugs market to grow at a CAGR of 9.48% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Medicine Technology: